Treatment of head and neck hemangiomas with recombinant interferon alpha 2b

Annals of Otology, Rhinology and Laryngology

Volumn 105, Issue 3, 1996, Pages 201-206

  Soumekh, Benhoor ^a,c   Adams, George L ^a,d   Shapiro, Ralph S ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

^d NONE   (United States)

Author keywords

hemangioma; interferon

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEVER; HEAD AND NECK SURGERY; HEMANGIOMA; HUMAN; IMMUNOTHERAPY; INFANT; LIVER TOXICITY; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0029933415     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949610500305     Document Type: Article

References (23)

1. Stal S, Hamilton S, Spira M. Hemangiomas, lymphangiomas and vascular malformations of the head and neck. Otolaryngol Clin North Am 1986;19:769-96.
2. Bartlett JA, Riding KH, Salkeld LI. Management of hemangiomas of the head and neck in children. J Otolaryngol 1988;17.111-20.
3. Mulliken JB, Glowacki J. Hemangiomas and vascular malformation in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-22.
4. Cohen SR, Wang C-I. Steroid treatment of hemangioma of the head and neck in children. Ann Otol Rhinol Laryngol 1972;81:584-90.
5. Enjolars O, Riche MC, Merland JJ, Escande JP. Management of alarming head and neck hemangiomas in infancy: a review of 25 cases. Pediatrics 1990;85:491-8.
6. Rebeiz E, April MM, Bohigian RK, Shapshay SM. Nd-YAG laser treatment of venous malformations of the head and neck: an update. Otolaryngol Head Neck Surg 1991;105:655-61.
7. Healy G, McGill T, Friedman EM. Carbon dioxide laser in subglottic hemangioma. An update. Ann Otol Rhinol Laryngol 1984;93:370-3.
8. Ezekowitz RAB, Mulliken JB, Folkman J. Interferon alpha-2a therapy for life threatening hemangiomas of infancy. N Engl J Med 1992;326:1456-63.
9. Ohlms LA, Jones DT, McGill TJI, Healy GB. Interferon alfa-2a therapy for airway hemangiomas. Ann Otol Rhinol Laryngol 1994;103:1-8.
10. Orchard P, Smith CM, Woods WG, Day DL, Dehner LP, Shapiro L. Treatment of hemangioendotheliomas with alpha interferon. Lancet 1989;2:565-7.
11. White CW, Wold SK, Koroner DN, Sondheimer HM, Tosi MF, Yu A. Treatment of childhood angiomatous diseases with recombinant interferon alpha-2a. J Pediatr 1991;118:59-66.
12. White CW. Treatment of hemangiomatosis with recombinant interferon alpha. Semin Hematol 1990;27:15-22.
13. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL. Treatment of pulmonary hemangiomatosis with recombinant alpha-2a. N Engl J Med 1989;320:1197-200.
14. Ricketts RR, Hatley RM, Corden BJ, Sabio H, Howell CG. Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood. Ann Surg 1994;219:605-14.
15. Loughnan MS, Elder J, Kemp A. Treatment of a massive orbital-capillary hemangioma with interferon alpha-2b: short-term results. Arch Ophthalmol 1992;110:1366-7.
16. Horn DB, Maisel RH. Angiogenic growth factors: their effects and potential in soft tissue wound healing. Ann Otol Rhinol Laryngol 1992;101:349-54.
17. Proctor SJ, Jackson G, Carey P, et al. Improvements of platelet counts in steroid-unresponsive idiopathic immune thrombocy topenic purpura after short-course therapy with recombinant alpha 2b interferon. Blood 1989;74:1894-987.
18. Groopman JE, Gottlieb MS, Goodman J, et al. Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984;100:671-6.
19. Real FX, Ottegen HF, Krown SE. Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon. J Clin Oncol 1986;4:544-51.
20. Sidky YA, Borden EC. Inhibition of angiogenesis by interferons: effect on tumor- and lymphocyte-induced vascular responses. Cancer Res 1987;47:5155-61.
21. Brouty-Bouye D, Zetter BR. Inhibition of cell motility by interferon. Science 1980;208:516-8.
22. Vilcek J, Gresser I, Merigan TC. Regulatory functions of interferons. Ann NY Acad Sci 1980:1-637.
23. Heyns AD, Eldor A, Vlodavsky I, Kaiser N, Fridman R, Panet A. The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events: studies with smooth muscle cells and endothelial cells. Exp Cell Res 1985;161:297-306.